The intravascular catheters market is set to reach US$ 8,051.7 Mn by 2028 from US$ 4,034.7 Mn in 2018 showcasing balanced growth at a compounded annual growth rate (CAGR) of 8.0% during the forecast period from 2019 to 2028. The major drivers associated with the intravascular catheters market growth are significant rise in inpatient surgical procedures in hospitals for treatment of chronic illness and increasing demand for catheters in minimal invasive surgical procedures conducted in catheterization labs & ambulatory care centers. Medical device manufactures are working diligently to minimize the risk associated with catheters such as phlebitis and catheter associated blood stream infection (CABSI).
"Low cost and easy insertion technique drives the market growth for short PIVC"
Short PIVC are reigning the product segment for intravascular catheters market. Healthcare professionals prefer short PIVC owing to its low cost and easy insertion technique in recommended sites such as wrist or antecubital vein etc. The limitation associated with short PIVC are the frequent movement of the inserted needle causes phlebitis, infiltration, and dislodgment thereby causing pain and discomfort to the ailing patient. Integrated PIVC are gaining huge traction owing to its inherent feature such as advanced stabilization frame which reduces inserted catheters movement and nullifies the need for add on securement devices. Use of integrated PIVC has reduced the occurrence of phlebitis and catheter associated blood stream infection (CABSI).
"Increasing demand for minimal invasive surgical procedures pertaining to trauma incidence and cardiovascular complication together drive the other applications"
Other applications are dominating the segment in the global intravascular catheters market. As per the statistics provided by World Health Organization (WHO), each year throughout the world 17.9 million people die due to cardiovascular complications. It represents 31% of all the deaths occurring worldwide, scientist opine that early surgical intervention can help in curbing this huge mortality rate. Increasing demand for minimal invasive surgical procedures related to cardiovascular disease and trauma cases together drive the other applications market growth. Infectious disease are on a rise in the tropical and subtropical regions due to the climate favoring microbial growth. Rising prevalence of hospital acquired infection and rising public health awareness will result in early medical interventions pertaining to infectious disease.
"Rising prevalence of hospital acquired infection and existence of sophisticated healthcare infrastructure drive the market growth in North America"
North America currently holds 32% market share and is the clear leader in the regional segment for intravascular catheters market. The important parameters contributing towards its market dominance are rising prevalence of hospital acquired infections and existence of sophisticated healthcare infrastructure. Presence of major players such as Terumo Corporation, Boston Scientific Corporation, Johnson & Johnson etc. further bolster the market growth in North America region. Europe is presently in the second position in the regional segment with 30% share owing to the favorable reimbursement scenario for intravascular catheters and significant rise in the number of impatient surgeries performed to treat chronic ailments. Asia Pacific represents 20% market share primarily due to huge population base suffering with cardiovascular and renal disorders and significant rise in medical tourism.
Medical device manufacturers providing intravascular catheters are Boston Scientific Corporation, Terumo Corporation, Medtronic, Plc., Getinge AB, Cook Medical, Johnson & Johnson, C.R.Bard, Inc., McKesson Medical Surgical, Inc., Edwards, Life Sciences Corporation and Coloplast A/S.
Historical & Forecast Period
This study report represents analysis of each segment from 2024 to 2034 considering 2025 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2026 to 2034.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Intravascular Catheters market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
| ATTRIBUTE | DETAILS |
|---|---|
| Research Period | 2024-2034 |
| Base Year | 2025 |
| Forecast Period | 2026-2034 |
| Historical Year | 2024 |
| Unit | USD Million |
| Segmentation | |
Product
|
|
Application
|
|
|
Region Segment (2024-2034; US$ Million)
|
Key questions answered in this report
